‘Wake-up call’ for real time monitoring

Pharmacy and medical bodies have written to the TGA, calling for national script monitoring to be implemented urgently In its consultation paper on options for a regulatory response regarding prescription strong (Schedule 8) opioid use and misuse in Australia, the TGA highlights that apart from possible TGA regulatory action, consideration should be given to the